Bovie Medical Corp. has applied for pre-market clearance from the Food and Drug Administration for a device designed for use in orthopedic surgeries.
The device, named BOSS, primarily will be targeted toward orthopedic hip and knee reconstruction surgeries, Bovie said in a release. There are more than 1.3 million such procedures performed in the United States annually, and the market is growing due to a move active and aging population. The worldwide market is expected to exceed $500 million this year, the release said.
BOSS is the latest generation device based on Bovie’s use of conductive sintered steel as an electrode for radio frequency cutting and coagulation. It is intended to lower blood loss, quicken procedure times and provide cost savings, Bovie said in a filing with the Securities and Exchange Commission.
Latest from Today's Medical Developments
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
- Manufacturing technology orders reach record high in December 2025
